Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer and Israeli Medical Center to Create Neonatal Screening Program in Israel

NEW YORK, June 8 (GenomeWeb News) - Israel's Chaim Sheba Medical Center has selected PerkinElmer's nenonatal screen technology to create a national newborn screening program, the company said today.

The neonatal screening initiative will be built around the company's AutoDELFIA automatic immunoassay system. PerkinElmer will deliver multiple AutoDELFIA units as well as reagents and equipment. 

Under the agreement, PerkinElmer will provide the center with instruments, reagents, scientific expertise, and an informatics system to enhance its neonatal screening and data-management capabilities.

Israel is following a mandate set by the Medical Research Infrastructure Development and Health Services Fund to substantially expand its newborn screening program to cover the entire population and to increase the number of tests screened for indications of disease.

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.